Acer Therapeutics Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Acer Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2023.
  • Acer Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$14.7M, a 194% decline year-over-year.
  • Acer Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$48.5M, a 128% decline year-over-year.
  • Acer Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$26.2M, a 70.7% decline from 2021.
  • Acer Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$15.4M, a 32.8% increase from 2020.
  • Acer Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$22.9M, a 22.2% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$48.5M -$14.7M -$9.72M -194% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$38.8M -$8.09M -$5.42M -203% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-20
Q1 2023 -$33.3M -$16.3M -$7.1M -77.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-11-20
Q4 2022 -$26.2M -$9.38M -$4.96M -112% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-27
Q3 2022 -$21.3M -$5.01M -$1.73M -53% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$19.5M -$2.67M +$402K +13.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-20
Q1 2022 -$19.9M -$9.18M -$4.57M -99.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-20
Q4 2021 -$15.4M -$4.42M +$1.82M +29.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 -$17.2M -$3.27M +$2.66M +44.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$19.8M -$3.07M +$2.7M +46.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$22.5M -$4.61M +$337K +6.82% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$22.9M -$6.24M -$1.08M -21% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-02
Q3 2020 -$21.8M -$5.93M -$677K -12.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-19
Q2 2020 -$21.1M -$5.77M +$5.27M +47.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-19
Q1 2020 -$26.4M -$4.95M +$3.02M +37.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-19
Q4 2019 -$29.4M -$5.16M +$3.34M +39.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$32.8M -$5.25M -$1.29M -32.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$31.5M -$11M -$6.21M -128% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$25.3M -$7.97M -$3.99M -100% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q4 2018 -$21.3M -$8.5M -$4.28M -102% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-18
Q3 2018 -$17M -$3.97M -$487K -14% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$16.5M -$4.84M -$1.71M -54.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-13
Q1 2018 -$14.8M -$3.98M -$604K -17.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-13
Q4 2017 -$14.2M -$4.21M -$3.66M -667% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$10.5M -$3.48M -$1.59M -84.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$8.94M -$3.12M -$1.02M -48.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$7.92M -$3.38M -$1.22M -56.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$6.7M -$549K +$2.53M +82.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$9.23M -$1.89M +$909K +32.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$10.1M -$2.1M +$689K +24.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$10.8M -$2.16M +$1.19M +35.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$12M -$3.08M +$275K +8.19% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-28
Q3 2015 -$12.3M -$2.79M +$1.08M +28% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-10
Q2 2015 -$13.4M -$2.79M +$1.37M +32.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-11-14
Q1 2015 -$14.7M -$3.35M +$305K +8.34% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$15.1M -$3.36M +$403K +10.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$15.5M -$3.88M +$1.85M +32.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$17.3M -$4.16M -$1.17M -38.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 -$16.1M -$3.66M +$522K +12.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 -$16.7M -$3.76M -$1.72M -84.8% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-23
Q3 2013 -$14.9M -$5.72M -$3.37M -143% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$11.6M -$3M -$832K -38.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$10.7M -$4.18M -$1.8M -76% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$8.93M -$2.03M -$157K -8.38% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-27
Q3 2012 -$8.77M -$2.36M -$1.06M -81.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$7.71M -$2.16M -$678K -45.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$7.03M -$2.37M -$1.07M -81.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$5.97M -$1.88M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-27
Q3 2011 -$1.3M -$6.46K -0.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$1.49M +$335K +18.4% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$1.31M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 -$1.29M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 -$1.82M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.